Breast milk has a well-known anti-microbial effect, which is in part due to the many different carbohydrate structures expressed. This renders it a position as a potential therapeutic for treatment of infection by different pathogens, thus avoiding the drawbacks of many antibiotics. In a previous study, we showed that pigs express the Helicobacter pylori receptors, sialyl Lewis x (Le x ) and Le b , on various milk proteins. Here, we investigate the pig breed-and individual-specific expression of these epitopes, as well as the inhibitory capacity of porcine milk on H. pylori binding and colonization. Milk proteins from three different pig breeds were analysed by western blotting using antibodies with known carbohydrate specificity. 
Introduction
Helicobacter pylori is a gram-negative bacterium whose main host is man. It resides in the gastric mucosa or adheres to the epithelial cells lining the stomach. Some 50% of the world population is infected by the bacterium, with a higher incidence in developing countries. H. pylori is associated with the development of peptic ulcer disease, mucosaassociated lymphoid-tissue (MALT) lymphoma and gastric adenocarcinoma (Blaser, 1996; Crespo and Suh, 2001) , and it has been classified as a carcinogen by the International Agency for Research on Cancer and the World Health Organization (IARC/WHO). The binding properties of H. pylori to different glycoconjugates have been extensively studied and a number of binding specificities identified Falk et al., 1993; Kamisago et al., 1996; Miller-Podraza et al., 1997; Roche et al., 2001) . The binding of H. pylori to different carbohydrate structures is mediated by adhesins expressed on its surface. Two of these, the BabA and the SabA adhesins have been purified and characterized (Ilver et al., 1998; Mahdavi et al., 2002) .
Today, treatment of H. pylori infection involves different antibiotics in combination with drugs reducing stomach acidity (Meurer and Bower, 2002) . However, the treatment is complicated by the occurrence of H. pylori strains resistant to commonly used antibiotics (Megraud, 2001) as well as patient allergy to antibiotics. Also, the benefit of eradicating H. pylori from its human host has been debated (Richter, 2001) . This, in conjunction with the overall negative effect that antibiotics may have on the human gastrointestinal microbiota, has led researchers to investigate new pathways for treatment of infection by H. pylori as well as other pathogens.
Breast milk is known to have a general anti-microbial effect (Hamosh, 1998) . In addition, milk contains free oligosaccharides and glycoconjugates such as glycoproteins and glycolipids (Newburg, 1995 (Newburg, , 1999 Burgoyne et al., 1998; Hamosh, 1998; Mather et al., 1998) believed to confer protection of the infant against a variety of different pathogens, for example H. pylori, by preventing pathogen adhesion (Holmgren et al., 1983; Andersson et al., 1986; Stromqvist et al., 1995; Peterson et al., 1998; Newburg, 1999; Schwertmann et al., 1999; Kunz et al., 2000; Herrera-Insua et al., 2001) . For instance, purified human milk κ-casein was shown to inhibit H. pylori adhesion to sections of human gastric mucosa (Stromqvist et al., 1995) and whole human milk inhibited H. pylori adhesion to Kato III cells, irrespective of whether or not the donor was infected with H. pylori (Clyne et al., 1997) .
Blocking of H. pylori adhesion to stomach epithelial cells may provide an alternative treatment for infected patients, presumably not resulting in eradication nor supporting the development of H. pylori strains resistant to antibiotics. The two adhesins expressed by H. pylori recognize and bind to the carbohydrate epitopes Lewis (Le) b (BabA) and sialyl Le x (SabA). These epitopes are therefore of major importance for the colonization and infection by H. pylori. As a consequence, Le b and sialyl Le x , or similar carbohydrate epitopes, may act as decoys for H. pylori thereby preventing H. pylori binding and colonization. A recent study by Ruiz-Palazios (Ruiz-Palacios et al., 2003) showed that the presence of the Campylobacter jejuni-binding epitope Fucα1-2Galβ1-4GlcNAc (H type 2) on mouse milk glycoconjugates, as a result of transgenic expression of the human α1,2-fucosyltransferase (FUT1) in the dams, could prevent infection by this bacterium in the suckling pups. This shows that the concept of blocking pathogen adhesion as a mean to prevent infection has potentials. However, earlier studies trying to interfere with protein-carbohydrate interactions between the pathogen and its host have been less successful. Mysore et al. (1999) treated H. pylori-infected rhesus monkeys with the free oligosaccharide NeuAcα2,3Galβ1,4Glc (3′-sialyllactose). This resulted in clearance of the pathogen in 50% of the animals, but in the animals that had a higher degree of colonization, H. pylori infection persisted. A potential multivalent presentation of the H type 2 antigen on mouse milk glycoproteins may explain the treatment efficacy observed by Ruiz-Palazios. Simple oligosaccharides, as used in the Mysore study, may not provide binding affinities high enough to accomplish efficient blocking of a microbe adhering to the mucosal cell by multiple attachment sites.
In a previous study (Gustafsson et al., 2005) 
Results

Characterization of H. pylori-binding epitopes on milk proteins from defined pig breeds
The expression of sialyl Le x and Le b in three different pig strains, Finnish Landrace (FL), Hungarian Large White (HLW), and a crossbreed between these two strains, HLW × FL, were examined.
Sialyl Le x expression was seen on milk proteins in several of the individual milk samples from the FL as well as the crossbreed, HLW × FL (Figure 1a and b; specific antibody (Figure 1) .
The FL pig milk samples all showed Le b reactivity on two major proteins of molecular masses around 100 kDa and 160 kDa. In addition, staining of a band with a very high molecular mass was seen in all samples (Figure 2a ). This could correspond to a large mucin-type protein or to some noncharged glycoconjugates, for example, glycosphingolipids, present in the sample but unable to migrate into the gel. In contrast, the HLW × FL crossbreed pig samples were all negative except for one stained component (∼150 kDa) in one individual (Figure 2b ). The HLW pig milk samples showed no reactivity at all with the anti-Le b antibody (Figure 2c) Figure 3a . All of the milk samples from the FL pigs had an inhibitory effect, and the milk from 8/10 FL pigs inhibited binding more than 70% compared to controls at a dilution of ×500. Among the crossbreeds, the milk from 3/6 pigs had an inhibitory effect exceeding 70%. The inhibitory effect of the milk from HLW pigs was less than 40% in 8/10 individuals at a dilution of ×500.
The sialyl Le x -specific strain CCUG17875DM was also tested for binding to sialyl-diLe x -HSA at different milk dilutions. As for the J99 strain, pig milk expressing sialyl Le x had a good inhibitory capacity on H. pylori CCUG17875DM binding to the sialyl-di-Le x -conjugate (data not shown). Milk from the FL breed showed an inhibition of more than 90% for 8/10 individuals at a milk dilution of ×200 and milk from the crossbreed had an inhibitory effect exceeding 50% at the same dilution. In contrast, the inhibitory effect of the milk from HLW pigs was marginal at a dilution of ×200, whereas at lower dilutions (×25) inhibitions approaching 75% were seen for some pigs. , and 8000 times in blocking buffer) and 125 I-labelled sialyl-di-Le x -HSA. The activity of the pellet (bound) as well as the supernatant (free) HSA-glycoconjugates were measured in a γ-counter and percent inhibition calculated as a function of the percentage of bound sialyl-di-Le x -HSA compared to a negative control (blocking buffer only). FL × HLW samples number 1 and 2 were omitted in the in vitro study due to low sample amount. (b) The milk titer value, that is, the milk dilution that resulted in a 50% reduction of sialyl-di-Le x -HSA binding to H. pylori, was plotted against the milk protein sialyl Le x expression in individual milk samples as calculated from the total optical density of anti-sialyl Le x (KM93) probed western blots (Figure 1a-c) . The dotted lines represent a 95% confidence interval, and the correlation coefficient is 0.76. Inhibition of H. pylori J99 binding to Le b conjugates by milk obtained from the different pig strains was in general weaker. At a dilution of ×50, the milk from 6/10 FL pigs inhibited Le b -conjugate binding by at least 80% compared to the controls (Figure 4a ). One of six crossbreed pigs inhibited binding by 70% at a milk dilution of ×50, whereas only one of the HLW pig milk samples had an inhibitory capacity of above 50% at this dilution.
A second H. pylori strain was tested also for binding to Le b -HSA, namely the Le b -specific strain CCUG17875/Le b (data not shown). At a dilution of ×200, the milk from 4/10 FL pigs inhibited Le b -conjugate binding by at least 50%. Of the crossbreeds, one of six inhibited binding by 50% at a milk dilution of ×100, whereas none of the HLW pig milk samples had this inhibitory capacity. the level of H. pylori colonization in the stomachs of Le bexpressing mice ( Figure 5 ). Milk from FL individuals had an inhibitory effect on H. pylori colonization in mice that was significantly stronger (P < 0.05) than that of milk from Le b -and sialyl Le x -nonexpressing HLW pigs ( Figure 5 ). The mean value of lactobacillus colonies in mice treated with milk from FL or HLW pig individuals were 7.8E+04 and 3.63E+04, respectively (difference not significant), whereas the mean value for mice treated with water was 1.51E+05.
Discussion
In the human stomach, H. pylori adhere to mucous-producing surface epithelial cells derived from the pit cell lineage . Binding is mediated by fucosylated blood group antigens, H type 1 and Lewis b , normally expressed on human gastric epithelium. Once bound, H. pylori exerts its pathogenic effect resulting in chronic atrophic gastritis and parietal cell loss (Guruge, J.L. et al., 1998) . The loss of acid-producing parietal cells was shown to be associated with the loss of mature zymogenic cells and an increased proliferation of gastric epithelial cell lineage progenitors (Syder et al., 1999) . The progenitors expressed a higher degree of sialylated structures, among them sialyl Le x , which promoted the binding of H. pylori. In another study, H. pylori infection in human and rhesus monkey gastric epithelium were shown to induce expression of the sialyl Le x antigen as part of the inflammatory response (Mahdavi et al., 2002) , thus providing the bacterium with additional attachment points that can be used for maintenance and local spread of the infection. A recent study also showed that the bacterium adapts its binding preferences according to the host population (Aspholm-Hurtig et al., 2004) . The specialized binding pattern of H. pylori might explain its extraordinary capability to uphold infection in its host, as well as in a population, for decades. The more severe outcomes of H. pylori infection, for example, adenocarcinoma, usually develop first after a long period of chronic infection. These facts make it especially important to find alternative treatments for H. pylori infection as compared to other pathogens, considering the risks of treating whole populations with antibiotics when only a smaller, unknown group of individuals will develop the more severe diseases associated with infection. (Mammen et al., 1998; Lee and Lee, 2000) . The protein backbone provides the mechanism needed for a multivalent presentation of the carbohydrate epitopes to their corresponding receptors. Therefore, protein-bound carbohydrate epitopes have an advantage over free oligosaccharides in inhibiting protein-carbohydrate interactions. Thus, the existence of the Le b and sialyl Le x carbohydrate epitopes on pig milk proteins is likely to mediate the major part of the H. pylori inhibitory capacity of the Le b -and sialyl Le x -expressing pig milk in this mouse model.
Milk proteins are mainly produced by the mammary epithelial cells and subsequently secreted from their apical surface by exocytosis (Burgoyne et al., 1998) . Milk lipids originate from the endoplasmic reticulum (ER) and are secreted enveloped by cellular membranes (Mather et al., 1998) . In humans, the milk fat globule (MFG) proteins are comprised of the mucins MUC-1 and MUC-X, lactadherin and butyrophilin. These proteins have been implicated to play a role in the protection of the infant against a number of pathogens (Peterson et al., 1998) . In particular, bovine MFG membranes were shown to inhibit sialic-acid dependent haemagglutination of H. pylori with an activity comparable to human gastrointestinal mucins (Hirmo et al., 1998) . Although the protein constitution of pig milk has not been explored in detail, it is likely to contain the same particular proteins found in milk from other animals (e.g., cow, goat). In fact, the profile of pig milk-glycosylated proteins strongly resembled the profile seen for cow colostrums (Gustafsson et al., 2005) known to contain abundant glycosylated proteins.
H. pylori binding to gastric tissue sections has been shown to colocalize with expression of MUC5AC ( Van de Bovenkamp et al., 2003) , a mucin expressed and secreted by gastric epithelial cells. Furthermore, the binding of H. pylori was closely associated with the expression of Le b on the same subset of cells. Also, purified Le b -expressing human MUC5AC has been shown to support binding of H. pylori, a binding that could be inhibited by Le b -HSA (Linden et al., 2002) . This implies that the natural ligand for H. pylori in the human stomach is a Le b -expressing mucin. Although man is the main host, H. pylori can also naturally colonize rhesus monkeys. A recent study showed that MUC5AC from this species express both Le b and sialyl Le x and that its binding of H. pylori was dependent on the expression of these carbohydrate epitopes .
In pig milk, Le b and sialyl Le x carbohydrate epitopes were seen on several proteins with a molecular weight of above 100 kDa. These proteins may be of the mucin type. Thus, pig milk may contain glycoconjugates similar to the ones utilized by H. pylori upon infection of its host. This, in conjunction with the high expression of glycosylated proteins including several expressing Le b and sialyl Le x , probably contributes to the high inhibitory capacity of pig milk on H. pylori binding.
Similar to humans (Sakamoto et al., 1989) , α1,3/4-fucosyltransferase FVB/N transgenic mice express the Le b antigen on gastric pit and surface mucous cells . H. pylori colonization of such mice results in epithelial attachment of the bacterium, active gastritis, and a mucosa-associated lymphoid infiltrate (Guruge et al., 1998) . Accordingly, H. pylori infection in the Le bexpressing FVB/N mouse exhibits some similarities to the pathological features of H. pylori infections in man. In contrast to humans, transgenic FVB/N mice were shown to express sialyl Le x also in noninflamed gastric pit and surface epithelium (Mahdavi et al., 2002) . Consequently, both receptor epitopes (Le b and sialyl Le x ) recognized by the H. pylori J99 strain used in our study, are present in this mouse model. Le b and sialyl Le x containing pig milk is likely to competitively block H. pylori attachment to mouse gastric epithelium and thereby prevent colonization.
The carbohydrate structures expressed on milk proteins are produced and processed in the ER and the Golgi of mammary gland epithelial cells. Although the pathway for synthesis of the complex oligosaccharides found in milk is not fully understood, it has been suggested that the synthesis starts with the addition of an N-acetylglucosamine (GlcNAc) to lactose by the β3-N-acetyl-glucosaminyltransferase (iGnT) usually acting on glycoproteins, and that the synthesis then continues in the same way as for protein-bound oligosaccharides (Kobata, 2003) . Hence, complex oligosaccharides present on milk glycoconjugates are likely to be expressed also in the oligosaccharide fraction of milk. This implies that the Le b and sialyl Le x structures found on pig milk proteins are likely to be present also as free oligosaccharides. The H. pylori binding specificity for free oligosaccharides and glycoconjugates expressing the same terminal carbohydrate epitope has been shown to differ , with a broader low affinity (see Discussion above) receptor specificity for free oligosaccharides. Even though they bind with lower affinity, free Le b and sialyl Le x oligosaccharides may contribute to the inhibitory capacity of pig milk on H. pylori colonization.
The expression of Le x and sialyl-Le a on one milk protein from the FL and the HLW × FL breeds further support the presence of one (or several) α1,3/4-fucosyltransferase(s) capable of utilizing type 1 and type 2 chains for the production of Lewis antigens on protein-bound glycans in the mammary epithelial cells of these pig breeds. H. pylori has been shown to bind to a number of different epitopes (Karlsson, 2000) , and it may be that these Lewis antigens to some extent contribute to the H. pylori inhibitory capacity seen for milk from the FL and the HLW × FL breeds. In particular, the J99 strain has been shown to recognize sialyl-Le a (Mahdavi et al., 2002) . However, the only binding epitopes for H. pylori so far where the receptors have been identified are the Le b and the sialyl Le x epitopes as mediated by the adhesins BabA and SabA, respectively (Ilver et al., 1998; Mahdavi, J. et al. 2002) . Consequently, the role of Lewis antigens other than Le b and sialyl Le x for the inhibitory capacity of pig milk on H. pylori binding can only be speculated upon.
In conclusion, we have shown that pig milk has the capacity to inhibit H. pylori binding in vitro and H. pylori colonization in vivo. This inhibitory effect is likely to be explained by (1) the multivalent expression of the carbohydrate epitopes Le b and sialyl Le x on high molecularweight pig milk proteins, supporting a presentation of these epitopes to H. pylori that mimics the natural ligands in its habitat, the human stomach and (2) the expression of the same epitopes on several different pig milk proteins, most likely increasing the likelihood of some of them being recognized by the H. pylori adhesins BabA and SabA. As a consequence, pig milk or milk from other animals either naturally, or transgenically, expressing the H. pylori-binding epitopes Le b and sialyl Le x might have a therapeutic effect on H. pylori infection. The use of such a therapeutic need not be limited to patients with already established H. pylori-associated diseases but could be used also in a preventive manner already at an earlier stage of infection. (Sakamoto et al., 1986) was purchased from Signet (Dedham, MA). Mouse anti-sialyl Le x antibody (IgM, clone KM93) recognizing NeuAc α2,3Galβ1,4(Fucα1,3)GlcNAc (Dohi et al., 1993; Kanoh et al., 2003) , mouse anti-Le x antibody (IgM, clone P12), mouse anti-sialyl-Le a antibody (IgG1, clone KM231), and mouse anti-Le a antibody (IgG1, clone T174) were purchased from Calbiochem-Novabiochem (San Diego, CA). The CSLEX (IgM) antibody recognizing NeuAc α2,3Galβ1,4(Fucα1,3)GlcNAc (Fukushima et al., 1984; Dohi et al., 1993; Mitsuoka et al., 1997) was produced by the CSLEX mouse hybridoma cell line (ATCC, Manassas, VA). HRP-conjugated goat anti-mouse IgM antibody was purchased from Cappel (Durham, NC).
Materials and methods
Chemicals and antibodies
Milk samples
Pig milk samples were collected from HLW, FL, and a crossbreed of HLW × FL. All samples were collected from animals that were in good health condition with no signs of clinical or subclinical mastitis.
Bacterial strains and culture
H. pylori strains J99 (Israel et al., 2001 ) (adhesion assay), CCUG 17875DM (Mahdavi et al., 2002) , CCUG17875/ Le b (Mahdavi et al., 2002) and CCUG17874 (Ilver et al., 1998) were grown on Brucella agar supplemented with 10% bovine blood and 1% IsoVitalex for two days in 10% CO2, 5% O2 at 37°C. H. pylori strain J99 (in vivo study) was grown on chocolage agar (CA) plates (Colombia agar, 8.5% horse blood, 10% horse serum) for 24 h at 37°C in a microaerophilic atmosphere (BBL GasPak Plus, Becton Dickinson and Company, Sparks, MD).
Determination of the total protein concentration in milk samples
Milk samples were frozen immediately upon collection and stored at −20°C until further processed. The protein concentration in individual milk samples was determined using the microtiter plate protocol of the BCA (bicinchoninic acid) Protein Assay Reagent (Pierce, Rockford, IL) according to the manufacturer's instructions. Samples were run in triplicate.
One-dimensional SDS-PAGE
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was run using 4-12% Bis-Tris discontinuous polyacrylamide gels (NuPAGE; Invitrogen, Carlsbad, CA) using a MES-buffer and nonreducing conditions. Before electrophoresis, individual milk samples were adjusted to a concentration of 3 mg/mL and, to avoid streaking, mixed with EDTA to a final concentration of 10 mM. A total protein amount of 11 μg was loaded per well. Separated proteins were visualized by a kit detecting glycosylated proteins by virtue of periodate oxidation of carbohydrate residues followed by conjugation to a fluorochrome emitting a bright green-fluorescent signal. Subsequently, the Ruby stain, which detects all proteins (Molecular Probes, Leiden, the Netherlands), was used.
Western blotting
Separated proteins were electrophoretically blotted onto nitrocellulose membranes (Invitrogen) using a Mini TransBlot electrophoretic transfer cell (Bio-Rad, Hercules, CA). Membranes were blocked overnight in phosphate-buffered saline with 0.2% Tween-20 (PBS-T) and 3% BSA, and subsequently washed with PBS-T. The membranes were incubated with primary and secondary antibodies diluted in blocking buffer for 1 h. Membranes were washed with PBS-T in between and after antibody incubations. Bound secondary reagents were detected using the ECL western blotting reagents (Amersham Biosciences, Uppsala, Sweden) followed by exposure of the membrane on Hyperfilm ECL (Amersham Biosciences).
H. pylori inhibiting milk titers versus pig milk Le b and sialyl Le x expression
The expression of Le b and sialyl Le x in individual pig milks was calculated from the total optical density using the Quantity One software (Bio-Rad, Hercules, CA). All films were exposed for 5 s and the background subtracted using a rolling disk value of 50. Bands were selected manually and the sum of all specific bands (Figures 1 and 2 
H. pylori adhesion assay
Milk samples were centrifuged for 1 h at 4°C at 39,000 g and subsequently cooled for removal of the top milk fat layer. The remaining skim milk part was used as sample and diluted in PBS-T with 1% BSA (blocking buffer). As a control, blocking buffer without milk sample was used. Two nanograms (sialyl diLe (Ilver et al., 1998) were used per mL reaction solution. Bacterial strains were diluted in blocking buffer to a final OD of 0.2 for J99 and CCUG17875DM used in the sialyl-diLe x assay and 0.001 for J99 and CCUG17875/Le b used in the Le b assay. Diluted milk was mixed with conjugate and bacteria and incubated for 2 h (sialyl-diLe x assay) or 17 h (Le b assay) in room temperature, centrifuged 13 min at 20,000 g, and supernatant sucked off and transferred to new tubes. The activity of the pellet (bound) as well as the supernatant (free) HSAglycoconjugates were measured in a γ-counter.
H. pylori colonization model in mice
Six-to eight-weeks-old male transgenic FVB/N mice expressing fucosylated blood group antigens were used for the experiment. Three groups of seven animals were colonized with a low passage J99 H. pylori strain. The J99 was grown on CA plates for 24 h at 37°C in a microaerophilic atmosphere. The mice were inoculated orally by gavage with 10 8 colony forming units (CFU)/mL of the H. pylori strain J99, two times a week for 2 weeks. They were housed in separate cages in a 12-h light-dark cycle and were fed a standard pellet diet. Two weeks after the last oral inoculation of H. pylori J99, the treatment with pig milk from FL (Le b /sLe x +) or HLW (Le b /sLe x -) pigs started. Four milliliters of milk were given per mouse to drink at will each day for a period of 9 days. Each mouse consumed all the milk during the day. At night, the mice had free access to water. The control group received only water. After treatment, the mice were sacrificed, and their stomachs were opened along the longer curvature using sterile instruments where after they were rinsed in sterile phosphate-buffered saline. The stomachs were homogenized and smeared on CA plates supplemented with 10% horse serum and 10 mg/mL vancomycin, 2500 IU/L polymyxin B and 5 mg/mL trimetoprim before they were incubated in a microaerophilic atmosphere at 37°C for 5 days. H. pylori J99 was identified as small translucent colonies containing gram-negative curved rods and by polymerase chain reaction (PCR) (35 cycles of 94°C for 30s, 50°C for 60s, and 72°C for 60s, extension for 15 min at 72°C) amplifying J99 BabA by specific primers (5′-3′ A10 forward: GCGTAG-GCTATCAAATCGGT and A19 reverse: GAAGAGGT-GCTTTCTTGACCATTAGCGTTACCCCGCATGCGT). The number of H. pylori J99 was estimated by colony count. The total amount of bacteria and lactobacilli was investigated by culturing the homogenized stomachs on blood agar plates and rogosa plates pH 5.5 (Merck, Darmstadt, Germany) incubated for 48 h at 37°C in an anaerobic atmosphere. The animal study was approved by the local animal ethics committee. 
Statistics
